Target intelligence / Profile preview

(3R)-hydroxyacyl-ACP dehydratase complex (HadABC) (HadABC)

Target
HadABC
Molecular classification
Enzyme, Lyase, Dehydratase
01

Overview

The (3R)-hydroxyacyl-ACP dehydratase complex (HadABC) is an essential enzyme system in Mycobacterium tuberculosis that plays a pivotal role in the Fatty Acid Synthase II (FAS-II) pathway (Sacco et al., 2007, PubMed: 17911131). This complex is responsible for the dehydration of (3R)-hydroxyacyl-acyl carrier protein (ACP) to trans-2-enoyl-ACP, a key step in the elongation of long-chain fatty acids that eventually form mycolic acids (Grzegorzewicz et al., 2012, PubMed: 22547444). Mycolic acids are indispensable components of the mycobacterial cell envelope, providing a thick, waxy barrier that protects the pathogen from host immune responses and antibiotics. The complex consists of three proteins—HadA, HadB, and HadC—which organize into functional heterodimers (HadAB and HadBC) to process different chain lengths of fatty acid substrates (UniProt: P9WNG1, P9WNG3, P9WNG5). Due to its essentiality and lack of a human homolog, the (3R)-hydroxyacyl-ACP dehydratase complex is a highly attractive target for the development of new anti-tuberculosis therapies. Drugs such as Isoxyl (Thiocarlide) and Thiacetazone specifically target this complex, leading to the inhibition of cell wall assembly and subsequent bacterial lysis (Brown et al., 2007, PubMed: 17449611).

Other names
HadABC dehydratase complexHadAB complexHadBC complexBeta-hydroxyacyl-ACP dehydrataseFAS-II dehydratase(3R)-hydroxyacyl-ACP dehydratase
02

Mechanism of action

Inhibition of the (3R)-hydroxyacyl-ACP dehydratase activity within the FAS-II system, preventing the elongation of fatty acids required for mycolic acid synthesis.

03

Biological functions

Mycolic acid biosynthesisFatty acid elongationCell wall synthesis
04

Disease associations

InfectionTuberculosis
05

Safety considerations

HepatotoxicityStevens-Johnson syndrome (associated with Thiacetazone)Drug resistance development
06

Interacting drugs

Isoxyl (Thiocarlide)

4 more in the full profile.

07

Biomarkers

Mycolic acid levelshadA/hadB/hadC gene mutationsBacterial load (CFU)

Beyond the preview

Go deeper on (3R)-hydroxyacyl-ACP dehydratase complex (HadABC) (HadABC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (3R)-hydroxyacyl-ACP dehydratase complex (HadABC) (HadABC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call